Partner Content Partner Content Key Opinion Leaders to present at the Respiratory Drug Deliv... Respiratory Drug Delivery
News Boehringer announces IPF deal with Korea's Bridge Biotherape... Boehringer Ingelheim and South Korean biotech Bridge Biotherapeutics have announced a deal to develop the latter’s drug for idiopathic pulmonary fibrosis (IPF).
Partner Content Partner Content Three Interactive Sessions to take place at the Respiratory ... Interactive Sessions at RDD
Partner Content Partner Content Registration is Live for the Inaugural Respiratory Drug Deli... Registration is Live for the Inaugural Respiratory Drug
Views & Analysis Propeller Health: respiring for success David Van Sickle is on a mission to transform treatment for respiratory diseases with the company he co-founded, Propeller Health.
News Lilly's 'triple G' retatrutide aces crucial obesity trial Lilly's retatrutide achieved weight loss of more than 30% at two years in a new trial, firming up its credentials as a next-generation obesity drug.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
